Shaw, L., Williams, R. L., & Hamill, K. J. (2020). CRISPR-Cas9-mediated labelling of the C-terminus of human laminin β1 leads to secretion inhibition. BMC Research Notes, 13(1), 1. https://doi.org/10.1186/s13104-020-04956-z
Chicago Style (17th ed.) CitationShaw, L., R. L. Williams, and K. J. Hamill. "CRISPR-Cas9-mediated Labelling of the C-terminus of Human Laminin β1 Leads to Secretion Inhibition." BMC Research Notes 13, no. 1 (2020): 1. https://doi.org/10.1186/s13104-020-04956-z.
MLA (9th ed.) CitationShaw, L., et al. "CRISPR-Cas9-mediated Labelling of the C-terminus of Human Laminin β1 Leads to Secretion Inhibition." BMC Research Notes, vol. 13, no. 1, 2020, p. 1, https://doi.org/10.1186/s13104-020-04956-z.
Warning: These citations may not always be 100% accurate.